Monthly Archives January 31, 2017

An opinion piece by MStranslate co-founder, Brett Drummond  As you may have seen recently, we have been running a series of MS: Many Stories articles written by one of our community members, Andrew.  As he...

Welcome to part 2 of a series of articles being written by MStranslate community member, Andrew.  You may recognise Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...

Research Summary: Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy A recent report in Lancet Neurology has highlighted two case studies of severe side effects in people with MS receiving...

Welcome to part 1 of a series of articles being written by MStranslate community member, Andrew.  You may recognise Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...

Research Summary: Liver injury associated with dimethyl fumarate in multiple sclerosis patients Last Friday, members of the Office of Surveillance and Epidemiology at the US FDA published a brief report in...

Research Summary: Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis There has been a lot of hype over ocrelizumab as the next ‘wonder drug’ in MS.  This has mostly come from the early...

An Opinion Piece by Brett Drummond, MStranslate Co-Founder With a new year beginning, we get a chance to look forward to what will happen in the field of multiple sclerosis research.  Some of this we can...